← All indications
Neuralgia
Intense or aching pain that occurs along the course or distribution of a peripheral or cranial nerve.
Subtype terms (6)
More specific conditions that are subtypes of Neuralgia in the MeSH hierarchy.
- Causalgia
4 drugs (1 approved, 3 experimental)
- Morton Neuroma
8 drugs approved
- Neuralgia, Postherpetic
87 drugs (40 approved, 47 experimental)
- Piriformis Muscle Syndrome
2 drugs (1 approved, 1 experimental)
- Pudendal Neuralgia
4 drugs (2 approved, 2 experimental)
- Sciatica
44 drugs (28 approved, 16 experimental)
Drugs by status
Approved for this indication (8)
Phase 4 trials (30)
- ketoprofen
- nabilone
- cetirizine
- ketamine
- oxycodone
- gabapentin
- carbamazepine
- metamizole
- rimabotulinumtoxinB
- ropivacaine
- acetaminophen
- magnesium sulfate
- lidocaine
- donepezil
- epinephrine
- levobupivacaine
- bupivacaine
- tramadol
- hydromorphone
- dexmedetomidine
- fentanyl
- methadone
- morphine
- naloxone
- sodium chloride
- venlafaxine
- ziconotide
- oxcarbazepine
- dexamethasone
- etoricoxib
Phase 3 trials (23)
Phase 2 trials (60)
Phase 1 trials (21)
Organizations
Organization Involved with Phase 4 Indications (90)
- Bausch Health Companies
- Grunenthal
- Astellas
- Gilead Sciences
- Merck
- Eli Lilly
- Merck KGaA
- Shionogi
- Novartis
- Allergan
- Analgesic Solutions
- Endo Pharmaceuticals
- Medy-Tox
- Boehringer Ingelheim
- National Institute of Neurological Disorders and Stroke (NINDS)
- NHS Greater Glasgow and Clyde
- Hospital Nacional de Parapléjicos de Toledo
- Universidade Estadual Paulista Júlio de Mesquita Filho
- Professional Associations Clinic Bergmannsheil
- Ziekenhuis Oost-Limburg
- Aarhus University
- University of Manitoba
- Albany Medical College
- Cardiovascular Institute of the South Clinical Research Corporation
- Case Western Reserve University
- Cedars-Sinai Medical Center
- University of London
- Cornell University
- Dankook University
- Duke University
- +60 more
Organization Involved with Phase 3 Indications (84)
- Daiichi Sankyo
- Eisai
- Takeda
- Cephalon
- Sanofi-Synthelabo
- Biogen
- Allodynic Therapeutics, LLC
- BioDelivery Sciences International
- Bunker Industria Farmaceutica Ltda.
- Hepion Pharmaceuticals
- Cristália Produtos Químicos Farmacêuticos Ltda.
- GlaxoSmithKline
- GW Pharmaceuticals Ltd.
- Hengrui Therapeutics, Inc.
- KunWha Pharmaceutical Co., Ltd.
- VanWorld Pharmaceutical (Rugao) Company Limited
- Bionorica
- Daewon Pharmaceutical Co., Ltd.
- Ontario Neurotrauma Foundation
- British Columbia Cancer Agency
- National Cancer Institute (NCI)
- National Institute of Allergy and Infectious Diseases (NIAID)
- Dr. Negrin University Hospital
- Central South University
- Alexandria University
- Brock University
- Eastern Virginia Medical School
- Faculdade de Medicina do ABC
- Guangzhou Medical University
- Hôpital Raymond Poincaré
- +54 more
Organization Involved with Phase 2 Indications (144)
- Zars Pharma Inc.
- Swedish Orphan Biovitrum
- AbbVie
- Methapharm
- Convergence Pharmaceuticals
- Savient Pharmaceuticals
- Spinifex Pharmaceuticals
- KAI Pharmaceuticals
- XenoPort, Inc.
- Vernalis
- Bristol-Myers Squibb
- Avigen
- Forest Laboratories
- AstraZeneca
- Genzyme
- Sanofi
- Avanir
- Aptinyx
- Purdue Pharmaceuticals
- Wyeth
- Aestus Therapeutics
- aRigen Pharmaceuticals, Inc.
- Cubist
- DARA Therapeutics
- Dong-A Pharmaceutical
- FGK Clinical Research GmbH
- INC Research
- Kyowa Hakko Kirin
- Kalypsys, Inc.
- Lexicon Pharmaceuticals
- +114 more
Organization Involved with Phase 1 Indications (25)
- Abide Therapeutics
- Cato Research
- Biomedical Development Corporation
- CDA Research Group, Inc.
- GL Pharm Tech Corporation
- Parexel
- Relmada Therapeutics, Inc.
- VistaGen Therapeutics, Inc.
- Creabilis SA
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- University of Michigan
- Chonbuk National University
- Tel Aviv University
- Orange County Research Center
- Free University of Amsterdam
- Wonju Christian Hospital
- University of Texas at Houston
- Universitair Ziekenhuis Gent
- Integrium
- Washington University in St. Louis
- General Electric
- ARENSIA EXPLORATORY MEDICINE
- Xalud Therapeutics, Inc.
- SIMR
- NeuroTherapia, Inc.
Organization Involved with Other Experimental Indications (40)
- Central Institute of Mental Health, Mannheim
- University of Pittsburgh
- Center for Clinical Studies, Texas
- HSK Wiesbaden
- Institut Guttmann
- Marmara University
- Neurological Associates of West Los Angeles
- Pain Relief & Palliative Care Center, Athens, Greece
- Shandong Provincial Hospital
- Shanxi Medical University
- Tanta University
- University of Heidelberg
- Fudan University
- Kangbuk Samsung Hospital
- Rosenberg European Academy of Ayurveda
- Taipei Medical University
- Zhejiang Chinese Medical University
- Tsinghua University
- University of Haifa
- Royal Marsden Hospital NHS Trust
- Tianjin Medical University
- P.D. Patel Ayurveda Hospital
- University of Oxford
- University of Montreal
- Medtronic
- University of Texas, San Antonio
- Johannes Gutenburg University
- National Institute for Health Research, United Kingdom
- Cangzhou Central Hospital
- Aretaieion University
- +10 more